Screening for medullary thyroid carcinoma: Experience with different immunoassays for human calcitonin

Wiener Klinische Wochenschrift

Volumn 114, Issue 7, 2002, Pages 267-273

  Bieglmayer, Christian ^a   Scheuba, Christian ^a   Niederle, Bruno ^a   Flores, Joan ^a   Vierhapper, Heinrich ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Calcitonin assays; Medullary thyroid carcinoma; Method comparison; Screening

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; NODULAR GOITER; SCREENING TEST; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT INDICATION; TREATMENT OUTCOME;

CALCITONIN; CARCINOMA, MEDULLARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOASSAY; IMMUNORADIOMETRIC ASSAY; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0037091109     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Tumor markers in diagnosis and screening
2. Routine calcitonin determination in thyroid nodules - An effective approach?
3. Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrinstimulated calcitonin
4. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin
5. Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis
6. Pentagastrin testing in patients with renal insufficiency: Normal responsivity of mature calcitonin
7. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary thyroid carcinoma
8. Routine measurements of serum calcitonin in nodular thyroid disease allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma
9. Prevalence of sporadic medullary thyroid carcinoma: The importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules
10. Interest of routine measurement of serum calcitonin: Study in a large series of thyroidectomized patients
11. Routine measurement of plasma calcitonin in nodular thyroid diseases
12. The extent of surgery for thyroid medullary cancer
13. Clinical evaluation of new assays for determination of serum calcitonin concentrations
14. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I
15. Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems
16. Nonspecific increases in plasma immunoreactive calcitonin in healthy individuals: Discrimination from medullary thyroid carcinoma by a new extraction technique
17. Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies
18. A comparison of the effects of intravenous pentagastrin an patients with social phobia, panic disorder and healthy controls
19. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin
20. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements
21. Interference cause false high calcitonin levels with a commercial assay